[
    [
        {
            "time": "2021-半年报",
            "orginal_text": "2021年基金半年报分析：双创板配置比例创新高 非银行金融遭主动减持 减持股份",
            "features": {
                "keywords": [
                    "双创板",
                    "配置比例",
                    "非银行金融",
                    "减持"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "双创板"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "2021年基金半年报分析：双创板配置比例创新高 非银行金融遭主动减持 减持股份",
            "scores": {
                "News_content": "2021年基金半年报分析：双创板配置比例创新高 非银行金融遭主动减持 减持股份",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "近期",
            "orginal_text": "北向资金净买入额创一个月新高连续8日加仓，伊利股份、贵州茅台净买入均超6亿元",
            "features": {
                "keywords": [
                    "北向资金",
                    "净买入",
                    "伊利股份",
                    "贵州茅台"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "食品饮料",
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "北向资金净买入额创一个月新高连续8日加仓，伊利股份、贵州茅台净买入均超6亿元",
            "scores": {
                "News_content": "北向资金净买入额创一个月新高连续8日加仓，伊利股份、贵州茅台净买入均超6亿元",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-09-01",
            "orginal_text": "因可转换债券获转换 药明康德(02359)9月1日发行8.3万股",
            "features": {
                "keywords": [
                    "药明康德",
                    "可转换债券",
                    "发行"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "因可转换债券获转换 药明康德(02359)9月1日发行8.3万股",
            "scores": {
                "News_content": "因可转换债券获转换 药明康德(02359)9月1日发行8.3万股",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-09-01",
            "orginal_text": "药明康德：于9月1日发行82,978股H股，每股发行价66.17港元",
            "features": {
                "keywords": [
                    "药明康德",
                    "H股",
                    "发行价"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "药明康德：于9月1日发行82,978股H股，每股发行价66.17港元",
            "scores": {
                "News_content": "药明康德：于9月1日发行82,978股H股，每股发行价66.17港元",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "近期",
            "orginal_text": "医药生物行业周报：医美行业强化监管 安徽省IVD集采结果公布",
            "features": {
                "keywords": [
                    "医药生物",
                    "医美",
                    "监管",
                    "IVD集采"
                ],
                "sentiment_score": -0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "医美"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "医药生物行业周报：医美行业强化监管 安徽省IVD集采结果公布",
            "scores": {
                "News_content": "医药生物行业周报：医美行业强化监管 安徽省IVD集采结果公布",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "近期",
            "orginal_text": "医药与健康护理行业月报：智飞生物新冠疫苗III期数据优异 对变异株仍然有效",
            "features": {
                "keywords": [
                    "医药",
                    "智飞生物",
                    "新冠疫苗",
                    "变异株"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药与健康护理行业月报：智飞生物新冠疫苗III期数据优异 对变异株仍然有效",
            "scores": {
                "News_content": "医药与健康护理行业月报：智飞生物新冠疫苗III期数据优异 对变异株仍然有效",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "近期",
            "orginal_text": "昭衍新药(603127)：产业链延伸加速 动物房产能持续扩张",
            "features": {
                "keywords": [
                    "昭衍新药",
                    "产业链",
                    "动物房",
                    "产能扩张"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "研发服务"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "昭衍新药(603127)：产业链延伸加速 动物房产能持续扩张",
            "scores": {
                "News_content": "昭衍新药(603127)：产业链延伸加速 动物房产能持续扩张",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "近期",
            "orginal_text": "港股医药股开盘走低，药明康德跌超4%，金思瑞生物跌超3%，药明生物、石药集团、微创医疗跌超2%",
            "features": {
                "keywords": [
                    "港股",
                    "医药股",
                    "药明康德",
                    "金思瑞生物",
                    "药明生物",
                    "石药集团",
                    "微创医疗"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "港股医药股开盘走低，药明康德跌超4%，金思瑞生物跌超3%，药明生物、石药集团、微创医疗跌超2%",
            "scores": {
                "News_content": "港股医药股开盘走低，药明康德跌超4%，金思瑞生物跌超3%，药明生物、石药集团、微创医疗跌超2%",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 10,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        },
        {
            "time": "近期",
            "orginal_text": "宁组合指数一度再跌近3%，隆基、石头科技、爱尔、爱美客、药明康德大幅下挫",
            "features": {
                "keywords": [
                    "宁组合指数",
                    "隆基",
                    "石头科技",
                    "爱尔",
                    "爱美客",
                    "药明康德"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "新能源",
                    "医药",
                    "消费"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "宁组合指数一度再跌近3%，隆基、石头科技、爱尔、爱美客、药明康德大幅下挫",
            "scores": {
                "News_content": "宁组合指数一度再跌近3%，隆基、石头科技、爱尔、爱美客、药明康德大幅下挫",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "近期",
            "orginal_text": "中信证券：港股市场有望迎来布局四季度行情的最佳窗口",
            "features": {
                "keywords": [
                    "中信证券",
                    "港股",
                    "四季度",
                    "布局"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "中信证券：港股市场有望迎来布局四季度行情的最佳窗口",
            "scores": {
                "News_content": "中信证券：港股市场有望迎来布局四季度行情的最佳窗口",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "近期",
            "orginal_text": "顶流基金经理布局新赛道，看好消费、创新医药",
            "features": {
                "keywords": [
                    "基金经理",
                    "新赛道",
                    "消费",
                    "创新医药"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "顶流基金经理布局新赛道，看好消费、创新医药",
            "scores": {
                "News_content": "顶流基金经理布局新赛道，看好消费、创新医药",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]